Mr. Andrew Maslan, CPA, Chief Financial Officer (CFO)
Mr. Maslan became the corporate controller on July 1, 2005 and the company’s CFO on August 15, 2005. Mr. Maslan most recently served as controller for BioReliance Corporation based in Rockville, Maryland, which was acquired by Invitrogen (IVGN-NASDAQ) in February 2004. Earlier, he held positions with two other Rockville, Maryland-based companies, serving as a principal with GlobeTraders, Inc., and senior accountant for Providence Laboratory Associates. Mr. Maslan began his professional career serving as an auditor with KPMG Peat Marwick. Mr. Maslan earned a Bachelor of Science degree in Accountancy from Miami University in Oxford, Ohio, and is a Certified Public Accountant in the State of Maryland.

Ms. Carelyn Fylling, R.N., M.S.N., is the Vice President of Professional Services, a position she has served since joining the Company’s new management team in December, 2001. Ms. Fylling was Director of Training and Program Development at the International Diabetes Center in Minneapolis, Minnesota. She provided consultative services nationally and internationally. She also has served on the national Board of Directors of the American Diabetes Association and numerous national committees. Ms. Fylling received the prestigious Ames Award for Outstanding Educator in the Field of Diabetes. Subsequently, she joined Curative Health Services and helped the company grow from three employees to over 650 employees. During her 13 years at Curative, Ms. Fylling helped to design the national wound database, developed clinical protocols, conducted outcome studies, trained physicians and nurses in comprehensive wound management, wrote scientific articles and abstracts, assisted in clinical trials and marketing, and developed an Internet-based online wound care training program for health professionals. Recently, she provided independent consulting and outsourcing services to the health care industry through Fylling Associates, LLC, which she wholly owns, and through Strategic Partners, LLC, in which she holds a partnership interest.

Mr. David A. Hotchkiss, Vice President, Sales and Marketing
Joining Cytomedix in October 2006, Mr. Hotchkiss has over 13 years of experience in the wound care market and leads the sales and marketing efforts for the company. Mr. Hotchkiss previously served as VP Sales and Marketing for Coloplast Corp. in Marietta GA, where he built successful sales and marketing teams and sound business strategies to support the wound, skin, continence and ostomy business units. His earlier wound care experience includes directing the sales and marketing efforts for Iodosorb, an antimicrobial wound dressing and for Carrington Laboratories, manufacturers of a full line of wound and skin products for the chronic patient.

In addition to sales and marketing, Mr. Hotchkiss has deep experience with product development, national accounts, reimbursement strategy, business development, market research and innovation management. He has participated as a member of the HIDA advisory panel, WOCN strategic planning and Frost and Sullivan Thought Leaders. Mr. Hotchkiss began his career as a sales representative with USV Labs/Rhone Poulenc Rorer, (now Sanofi Aventis) and advanced through increasingly responsible marketing management positions. He earned his Bachelors of Business Administration in Marketing from the University of North Texas, and has completed advanced studies at UCLA and JL Kellogg.

Eduardo March, Director of Quality Assurance and Regulatory Affairs
Mr. March joined Cytomedix in February, 2005, as its Director of Quality Assurance and Regulatory Affairs with more than 25 years of regulatory experience. Mr. March started his career as a Presidential Internship Award winner working at the Naval Aerospace Medical Research Laboratory in Pensacola, Florida. Following his work there and later with the Department of Defense, he joined the FDA in 1980, holding a number of positions in the Office of Device Evaluation and as a Compliance Officer for the Office of Compliance in the Center for Devices and Radiological Health. He was promoted to Assistant Director of the Division of Standards Enforcement, Office of Compliance where he directed the program for evaluating the conformance of medical devices to voluntary standards. Since 1994 and leaving FDA, Mr. March has been employed as a Senior Consultant to industry in the medical device regulatory area preparing applications for FDA approval of new medical devices and providing advice on FDA’s Quality System Regulation. He is an active member of the Regulatory Affairs Professional Society and the Association for the Advancement of Medical Instrumentation. Mr. March received a B.S. in Aerospace Engineering and M. S. degrees in Bioengineering and Management Science.